A slowdown in the economy and a massive influx of counterfeit drugs are among the major reasons drug makers in Nigeria have a hard time reaping the benefits of operating in a populous market.
Since 2015, sales in the Nigerian pharmaceutical industry have declined by 35.7 percent with no signs of
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
